The acute respiratory distress syndrome (ARDS) is a clinical syndrome with primarily
supportive management options. Despite extensive basic and clinical investigations …

Overall, there is no proven pharmacological therapy in ARDS, but some pharmacological
interventions were associated with beneficial effects in certain subgroups of patients …

Pharmacological treatments for acute respiratory distress sy... : Current Opinion in Critical Care
Pharmacological treatments for acute respiratory distress syndrome : Current Opinion in …

Introduction Acute respiratory distress syndrome (ARDS) is characterized by acute
inflammatory injury to the lungs, alterations in vascular permeability, loss of aerated tissue …

Introduction: The acute respiratory distress syndrome (ARDS) is a common and catastrophic
condition, with a high mortality rate and economic burden on society. Despite 50 years of …

Acute respiratory distress syndrome (ARDS) is an inflammatory process caused by a variety
of direct and indirect injuries to the lungs. Despite improvements in supportive care and …

To date, the only therapeutic option that has convincingly been shown to decrease mortality
in acute respiratory distress syndrome (ARDS) has been to use a lung-protective strategy …

Introduction Ventilatory management and general supportive care of acute respiratory
distress syndrome (ARDS) in the adult population have led to significant clinical …

Introduction There is still no definite drug for acute respiratory distress syndrome (ARDS)
that is capable of reducing either short-term or long-term mortality. Therefore, great efforts …

Objective: To review the pathophysiology, epidemiology, and therapy of patients with acute
respiratory distress syndrome (ARDS). Data Sources: Articles pertaining to the …